Antibiotic             2010 (n=100)             2011(n=100)              2012(n=100) Average  
  R % % S             R % % S                R
%
% S              Resistant    %
Ampicillin  87(95)
8.4
91.6 8( 95)       98(98) 100
0
0(98)           100(100)
0
100 0(100)         95(97.7) 97.2
Cephelaxin  81(93)
13
87.1 12( 93)        95(98)
3.1
97 3(98)          87(89)
2.2
97.7 2(89)          87.7 (93.3) 94
Cefotaxime  88(96)
8.3
91.7 8( 96)       68(68) 100
0
0(68)           64(64)
0
100 0(64)            73.3 (76) 96.4
Cloxacillin 100(100) 100 0(100) 100(100) 100
0
0(100)        100(100)
0
100 0(100)         100(100) 100
Erythromycin  76(93)
18.3
81.7 17(93)       78(96)
18.7
81.2 18(96)       82(97)
15.5
84.5 15(97)       78.7(95.3) 82.6
Gentamycin  62(90)
31.1
68.9 28(90)       71(100)
29
71 29(100)     87(98)
11.2
88.8 11(98)       73.3(96) 76.3
Ciprofloxacillin  52(91)
42.8
57.1 39(91)       39(97)
59.8
40.2 58(97)       64(97)
34.0
66 33(97)      51.7(95) 54.4
Clindamycin - -
-
-                  24(67)
64.2
35.8 43(67)       41(94)
56.4
43.6 53(94)      32.5(80.5) 40.4
Linezolid 0(100)
100
0 100(100)    0(100) 0
0
100(100)     0(100)
100
0 100(100)    0(100) 0
Vancomycin 0(100)
100
0 100(100)    0(100) 0
0
100(100)      0(100)
100
0 100(100)    0(100) 0
Table 1: Susceptibility to various antibiotics in the three years of sample collection (n=300)